Pharmacokinetics, Pharmacodynamics, and Safety of Moss-aGalactosidase A in Patients With Fabry Disease
Clinical trial NCT02995993 · COMPLETED
Trial details
- NCT number
- NCT02995993
- Sponsor
- Greenovation Biotech GmbH
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-10-09
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.